Report post

Who is incannex?

Incannex | Global leaders in cannabinoid & psychedelic therapies. Our mission is to alleviate human suffering by creating novel, ethical drugs and therapies for patients with unmet medical needs, utilising compounds and delivery systems with strong pre-existing scientific signals of efficacy.

How many clinical trials & R&D programs does incannex have?

28 R&D programs and 6 clinical trials, with 1 primary goal – alleviate human suffering. Incannex is a medicinal cannabinoid and psychedelic therapy development company undertaking phase 2 clinical trials guided by its extended team, post liaison with FDA.

Does incannex trade on the Australian Securities Exchange (ASX)?

*Please note all displayed share data on this website has a 20 minutes delay *All displayed share data on this website has a 20 minutes delay Incannex trades on the Australian Securities Exchange (ASX) under the ticker code IHL.

The World's Leading Crypto Trading Platform

Get my welcome gifts